Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Medicinas Complementárias
Métodos Terapéuticos y Terapias MTCI
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Homeopathy ; 108(3): 188-200, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-30999383

RESUMEN

INTRODUCTION: Encephalitozoon cuniculi (E. cuniculi), a fungus that acts as an intracellular pathogen, causes a marked neurological syndrome in many host species and is a zoonotic concern. Although no well-established treatment for this syndrome is known, previous successful clinical experience using homeopathic phosphorus has been described in which symptom remission with no mortality occurred in 40/42 animals by means of unknown immunological mechanisms. The latter observation was the main motivation for this study. OBJECTIVE: To verify, in an in-vitro model, if macrophages infected with E. cuniculi can change in function after treatment with different potencies of phosphorus. MATERIALS AND METHODS: RAW 264.7 macrophages were infected with E. cuniculi in-vitro and treated with various homeopathic potencies of phosphorus. The vehicle was used as a control solution (0.06% succussed ethanol). After 1 and 24 hours, the following parameters were analyzed: parasite internalization (by the Calcofluor staining method), lysosome activity (by the acridine orange method), cytokine/chemokine production (by the MAGPIX system), and cell ultrastructure. Automatic image analysis was used when applicable, and the experiments were performed in triplicate. RESULTS: Treatment with vehicle alone increased interleukin (IL)-6, tumor necrosis factor alpha and monocyte chemotactic protein -1 production (p ≤ 0.05) and reduced the number of internalized parasites (p ≤ 0.001). A progressive and time-dependent increase in RANTES (regulated on activation, normal T-cell expressed and secreted) and lysosome activity (p ≤ 0.002) was observed only after treatment with the highest potency of phosphorus (Phos 200cH), together with decreased apoptosis rate, intense parasite digestion, and the presence of non-internalized spores. CONCLUSIONS: Phos 200 cH has a modulatory action on the activity of infected macrophages, especially a specific increase in RANTES, a key element in the prognosis of E. cuniculi-infected and of immunosuppressed patients bearing infections.


Asunto(s)
Encephalitozoon cuniculi/efectos de los fármacos , Macrófagos/efectos de los fármacos , Fósforo/uso terapéutico , Animales , Encephalitozoon cuniculi/patogenicidad , Encefalitozoonosis/tratamiento farmacológico , Homeopatía/métodos , Homeopatía/normas , Macrófagos/microbiología , Fosfatos/uso terapéutico , Conejos
2.
Artículo en Inglés | MEDLINE | ID: mdl-25093026

RESUMEN

We evaluated the preventive and therapeutic effects of aqueous suspensions of garlic, tomato, and garlic + tomato in the development of experimental Ehrlich tumors in mice. The aqueous suspensions (2%) were administered over a short term for 30 days before tumor inoculation and 12 days afterward, and suspensions at 6% were administered for 180 days before inoculation and for 12 days afterward. The volume, number, and characteristics of the tumor cells and AgNOR counts were determined to compare the different treatments. Aqueous 6% suspensions of garlic, tomato, and garlic + tomato given over the long term significantly reduced tumor growth but when given over the short term, they did not alter tumor growth.

3.
Arq Neuropsiquiatr ; 66(2B): 378-84, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18641876

RESUMEN

The ethidium bromide-demyelinating model (EB) was used to study remyelination in the brainstem under the use of cyclosporine (CsA). Wistar rats were submitted to intracisternal injection of 0.1% EB or 0.9% saline solution, and others were taken as histologic controls (group I). Within those injected with EB, some have not received immunosuppressive treatment (II); some were treated by intraperitonial route with CsA (III.E-10 mg/kg/day). Rats from group III.C were injected with saline solution and treated with CsA. The animals were perfused from 15 to 31 days post-injection collecting brainstem sections for light and transmission electron microscopy studies. After EB injection it was noted the presence of macrophages and non-degraded myelin debris, demyelinated axons, oligodendrocyte or Schwann cell remyelinated axons, groups of infiltrating pial cells, hypertrophic astrocytes and few lymphocytes. Tissue repair of EB-induced lesions in group III.E was similar to that of group II, but with the presence of a higher density of oligodendrocytes near remyelinating areas.


Asunto(s)
Tronco Encefálico/efectos de los fármacos , Ciclosporina/uso terapéutico , Enfermedades Desmielinizantes/patología , Inmunosupresores/uso terapéutico , Neuroglía/ultraestructura , Animales , Tronco Encefálico/citología , Tronco Encefálico/fisiología , Tronco Encefálico/ultraestructura , Enfermedades Desmielinizantes/inducido químicamente , Enfermedades Desmielinizantes/tratamiento farmacológico , Enfermedades Desmielinizantes/fisiopatología , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Etidio , Macrófagos/efectos de los fármacos , Macrófagos/ultraestructura , Masculino , Microscopía Electrónica de Transmisión , Vaina de Mielina/efectos de los fármacos , Vaina de Mielina/fisiología , Neuroglía/efectos de los fármacos , Neuroglía/fisiología , Oligodendroglía/efectos de los fármacos , Oligodendroglía/ultraestructura , Ratas , Ratas Wistar , Células de Schwann/efectos de los fármacos , Células de Schwann/ultraestructura
4.
Arq. neuropsiquiatr ; 66(2b): 378-384, jun. 2008. ilus
Artículo en Inglés | LILACS | ID: lil-486195

RESUMEN

The ethidium bromide-demyelinating model (EB) was used to study remyelination in the brainstem under the use of cyclosporine (CsA). Wistar rats were submitted to intracisternal injection of 0.1 percent EB or 0.9 percent saline solution, and others were taken as histologic controls (group I). Within those injected with EB, some have not received immunosuppressive treatment (II); some were treated by intraperitonial route with CsA (III.E - 10 mg/kg/day). Rats from group III.C were injected with saline solution and treated with CsA. The animals were perfused from 15 to 31 days post-injection collecting brainstem sections for light and transmission electron microscopy studies. After EB injection it was noted the presence of macrophages and non-degraded myelin debris, demyelinated axons, oligodendrocyte or Schwann cell remyelinated axons, groups of infiltrating pial cells, hypertrophic astrocytes and few lymphocytes. Tissue repair of EB-induced lesions in group III.E was similar to that of group II, but with the presence of a higher density of oligodendrocytes near remyelinating areas.


Empregou-se o modelo desmielinizante do brometo de etídio (BE) com o objetivo de estudar a remielinização no tronco encefálico frente ao uso de ciclosporina (CsA). Foram utilizados ratos Wistar, submetidos à injeção de BE a 0,1 por cento ou de solução salina na cisterna pontina, assim como controles histológicos (grupo I). Dos animais injetados com BE, alguns não receberam tratamento imunossupressor (II); outros foram tratados por via intraperitoneal com CsA (III.E - 10 mg/kg/dia). O grupo III.C incluiu animais injetados com salina e tratados com CsA. Os animais foram perfundidos dos 15 aos 31 dias pós-injeção, com colheita de material do tronco encefálico para estudos de microscopia de luz e eletrônica de transmissão. Após injeção de BE, foram observados macrófagos e restos de mielina não-degradada, axônios desmielinizados ou remielinizados por oligodendrócitos e por células de Schwann, grupos de células piais infiltrantes, astrócitos hipertróficos e poucos linfócitos. O processo de reparo das lesões no grupo III.E apresentou-se similar ao do grupo II, porém com maior densidade de oligodendrócitos próximos às áreas de remielinização.


Asunto(s)
Animales , Masculino , Ratas , Tronco Encefálico/efectos de los fármacos , Ciclosporina/uso terapéutico , Enfermedades Desmielinizantes/patología , Inmunosupresores/uso terapéutico , Neuroglía/ultraestructura , Tronco Encefálico/citología , Tronco Encefálico/fisiología , Tronco Encefálico/ultraestructura , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Enfermedades Desmielinizantes/inducido químicamente , Enfermedades Desmielinizantes/tratamiento farmacológico , Enfermedades Desmielinizantes/fisiopatología , Etidio , Microscopía Electrónica de Transmisión , Macrófagos/efectos de los fármacos , Macrófagos/ultraestructura , Vaina de Mielina/efectos de los fármacos , Vaina de Mielina/fisiología , Neuroglía/efectos de los fármacos , Neuroglía/fisiología , Oligodendroglía/efectos de los fármacos , Oligodendroglía/ultraestructura , Ratas Wistar , Células de Schwann/efectos de los fármacos , Células de Schwann/ultraestructura
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA